Peripheral Blood-Based Biomarkers for Immune Checkpoint Inhibitors by Ho Jung An, Hong Jae Chon, Chan Kim

Get full text

Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors by Chang-Myung Oh, Hong Jae Chon, Chan Kim

Get full text

Combination Immunotherapies to Overcome Intrinsic Resistance to Checkpoint Blockade in Microsatellite Stable Colorectal Cancer by Chang Woo Kim, Hong Jae Chon, Chan Kim

Get full text

Could We Predict the Response of Immune Checkpoint Inhibitor Treatment in Hepatocellular Carcinoma? by Choong-kun Lee, Stephen L. Chan, Hong Jae Chon

Get full text

Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity by Won Suk Lee, Hannah Yang, Hong Jae Chon, Chan Kim

Get full text

Combining Cancer Vaccines with Immunotherapy: Establishing a New Immunological Approach by Chang-Gon Kim, Yun-Beom Sang, Ji-Hyun Lee, Hong-Jae Chon

Get full text

Impact of Coronavirus Disease 2019 on Unresectable Hepatocellular Carcinoma Treated with Atezolizumab/Bevacizumab by Yun Beom Sang, Chaeryoung Lee, Seul-Gi Kim, Boyoung Lee, Beodeul Kang, Chan Kim, Hong Jae Chon

Get full text

Atezolizumab/Bevacizumab vs. Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Real-World, Multi-Center Study by Beom Kyung Kim, Jaekyung Cheon, Hyeyeong Kim, Beodeul Kang, Yeonjung Ha, Do Young Kim, Seong Gyu Hwang, Young Eun Chon, Hong Jae Chon

Get full text

Atezolizumab plus bevacizumab in patients with child–Pugh B advanced hepatocellular carcinoma by Jaekyung Cheon, Hyeyeong Kim, Han Sang Kim, Chang Gon Kim, Ilhwan Kim, Beodeul Kang, Chan Kim, Sanghoon Jung, Yeonjung Ha, Hong Jae Chon

Get full text

Predictive biomarkers of survival in patients with advanced hepatocellular carcinoma receiving atezolizumab plus bevacizumab treatment by Young Eun Chon, Jaekyung Cheon, Hyeyeong Kim, Beodeul Kang, Yeonjung Ha, Do young Kim, Seong Gyu Hwang, Hong Jae Chon, Beom Kyung Kim

Get full text

Combination of Irreversible Electroporation and STING Agonist for Effective Cancer Immunotherapy by Eun-Jin Go, Hannah Yang, Hong Jae Chon, DaSom Yang, WonHyoung Ryu, Dong-Hyun Kim, Dong Keun Han, Chan Kim, Wooram Park

Get full text

PB101, a VEGF- and PlGF-targeting decoy protein, enhances antitumor immunity and suppresses tumor progression and metastasis by Eun-Jin Go, Hannah Yang, Seung Joon Lee, Hyun Gul Yang, Jin A. Shin, Won Suk Lee, Hye Seong Lim, Hong Jae Chon, Chan Kim

Get full text

High Serum Levels of IL-6 Predict Poor Responses in Patients Treated with Pembrolizumab plus Axitinib for Advanced Renal Cell Carcinoma by Yun Beom Sang, Hannah Yang, Won Suk Lee, Seung Joon Lee, Seul-Gi Kim, Jaekyung Cheon, Beodeul Kang, Chang Woo Kim, Hong Jae Chon, Chan Kim

Get full text

Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis by Jaekyung Cheon, Hong Jae Chon, Yeonghak Bang, Neung Hwa Park, Jung Woo Shin, Kang Mo Kim, Han Chu Lee, Jooho Lee, Changhoon Yoo, Baek-Yeol Ryoo

Get full text

Efficacy and safety of second-line nab-paclitaxel plus gemcitabine after progression on FOLFIRINOX for unresectable or metastatic pancreatic ductal adenocarcinoma: multicenter retr... by Heejung Chae, Hyehyun Jeong, Jaekyung Cheon, Hong Jae Chon, Hyewon Ryu, Il-Hwan Kim, Myoung Joo Kang, Jae Ho Jeong, Baek-Yeol Ryoo, Kyu-pyo Kim, Changhoon Yoo

Get full text

The presence and size of intrahepatic tumors determine the therapeutic efficacy of nivolumab in advanced hepatocellular carcinoma by Han Sang Kim, Chang Gon Kim, Jung Yong Hong, Il-hwan Kim, Beodeul Kang, Sanghoon Jung, Chan Kim, Sang Joon Shin, Hye Jin Choi, Jaekyung Cheon, Hong Jae Chon, Ho Yeong Lim

Get full text

Thyroid Dysfunction after Atezolizumab and Bevacizumab Is Associated with Favorable Outcomes in Hepatocellular Carcinoma by Young Shin Song, Hannah Yang, Beodeul Kang, Jaekyung Cheon, Ilhwan Kim, Hyeyeong Kim, Won Suk Lee, Yun Beom Sang, Sanghoon Jung, Ho Yeong Lim, Vincent E. Gaillard, Chan Kim, Hong Jae Chon

Get full text

High serum IL-6 correlates with reduced clinical benefit of atezolizumab and bevacizumab in unresectable hepatocellular carcinoma by Hannah Yang, Beodeul Kang, Yeonjung Ha, Sung Hwan Lee, Ilhwan Kim, Hyeyeong Kim, Won Suk Lee, Gwangil Kim, Sanghoon Jung, Sun Young Rha, Vincent E. Gaillard, Jaekyung Cheon, Chan Kim, Hong Jae Chon

Get full text

Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade by Jeong Hun Kim, Won Suk Lee, Seung Joon Lee, Hannah Yang, Hong Jae Chon, Chan Kim, Jin Hyoung Kim, Byung cheol Ahn, Dong Sung Kim, Yoonki Heo, Eun-Jin Go, Jung Sun Yum

Get full text

Real-world efficacy and safety of nab-paclitaxel plus gemcitabine-cisplatin in patients with advanced biliary tract cancers: a multicenter retrospective analysis by Jaekyung Cheon, Choong-kun Lee, Yun Beom Sang, Hye Jin Choi, Min Hwan Kim, Jun Ho Ji, Kwang Hyun Ko, Chang-Il Kwon, Dae Jung Kim, Sung Hoon Choi, Chan Kim, Beodeul Kang, Hong Jae Chon

Get full text